XIFANANTA Film-coated tablet Ref.[7348] Active ingredients: Rifaximin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2017  Publisher: Norgine Pharmaceuticals Ltd, Moorhall Road, Harefield, Middlesex, UB9 6NS

Therapeutic indications

Xifaxanta 200mg film-coated tablets are indicated for the treatment of travellers' diarrhoea that is not associated with any of:

  • Fever.
  • Bloody diarrhoea.
  • Eight or more unformed stools in the previous 24h.
  • Occult blood or leucocytes in the stool.

Xifaxanta 200mg film-coated tablets may shorten the duration of diarrhoea when this is associated with non-invasive strains of E.coli (see sections 4.4 and 5.1).

Posology and method of administration

Posology

200 mg every 8 hours for three days (total 9 doses).

Rifaximin must not be used for more than 3 days even if symptoms continue and a second course of treatment must not be taken (see section 4.4).

Rifaximin can be administered with or without food.

Paediatric population

The safety and efficacy of Xifaxanta 200 mg film-coated tablets in children (aged less than 18 years) have not been established

Elderly

No dosage adjustment is necessary as the safety and efficacy data of Xifaxanta 200 mg film-coated tablets showed no differences between the elderly and the younger patients.

Hepatic impairment

A dosage adjustment for patients with hepatic insufficiency is not necessary (see section 5.2).

Renal impairment

Although dosing change is not anticipated, caution should be used in patients with impaired renal function (see section 5.2).

Method of administration

Orally with a glass of water.

Overdose

In clinical trials with patients suffering from travellers' diarrhoea doses of up to 1800 mg/day have been tolerated without any severe clinical signs.

Dosages of up to 2400 mg/day for 7 days in patients/subjects with normal bacterial flora rifaximin did not result in any relevant clinical symptoms related to the high dosage.

In case of overdose symptomatic treatments and supportive care are recommended.

Shelf life

Original packaging: 3 years.

Special precautions for storage

This medicinal product does not require any special storage conditions.

Nature and contents of container

PVC/PE/PVDC-Aluminium blister pack containing 9 tablets.

Special precautions for disposal and other handling

No special requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.